as on February 2, 2026 at 4:01 pm IST
Day's Low
Day's High
3.42%
Downside
0.66%
Upside
52 Week's Low
52 Week's High
4.35%
Downside
55.65%
Upside
as on February 2, 2026 at 4:01 pm IST
Market Cap
₹20,168.68 Cr
Return on Equity (ROE)
9.76
PE Ratio (TTM)
-122.36
Return on capital employed (ROCE)
12.31
Industry PE ratio
40.1
Beta (LTM)
1.22
P/B Ratio
3.99
Dividend Yield
0.06
PEG Ratio
79.46
Quarterly Earnings Growth YOY
-3800.82
EPS (TTM)
0.69
Sector
Pharmaceuticals
Book Value
61.35
Technical Analysis
Bearish
View Technical Analysis
as on February 2, 2026 at 4:01 pm IST
Piramal Pharma in the last 5 years
Lowest (-1134.06x)
October 29, 2025
Today (-122.36x)
February 1, 2026
Industry (40.10x)
February 1, 2026
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: -122.36x
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 20,168.68 | -4.03% | 0.69 | 91 | 9,151 | |
| BUY | 14,151.16 | -4.35% | 0.68 | 264 | 1,197 | |
| BUY | 15,417.85 | 3.98% | 0.71 | 836 | 7,234 | |
| BUY | 4,335.61 | -5.82% | 1.88 | -343 | 71 | |
| BUY | 11,622.43 | 30.84% | 0.67 | 244 | 1,515 |
Based on 10 analysts
90.00%
Buy
0.00%
Hold
10.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Piramal Pharma. Average target price of ₹208.6
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Piramal Pharma.
What analysts predicted
37.48%UPSIDE
Target Price
₹208.6
Current Price
₹155.06
Analyzed by
10 Analysts
High
₹285
Target
₹208.60
Low
₹160
Piramal Pharma target price ₹208.6, a slight upside of 37.48% compared to current price of ₹155.06. According to 10 analysts rating.
Source: S&P Global Market Intelligence
Investment in Piramal Pharma Ltd Shares on INDmoney has grown by 18.40% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:18.40% versus previous 30 day period
Search interest for Piramal Pharma Ltd Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:34% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd’s net profit fell -3800.82% since last year same period to ₹-136.19Cr in the Q3 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated -37.26% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.09%.
Read More about DividendsCheck stock indices that include Piramal Pharma.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 2.03K Cr → 2.19K Cr (in ₹), with an average increase of 3.8% per quarter
MF Holding Up
![]()
Mutual Funds have increased holdings from 13.11% to 14.03% in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.1% return, outperforming this stock by 60.7%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 159.4% return, outperforming this stock by 107.7%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 34.86% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 1 month, PPLPHARMA stock has moved down by -15.0%
Profit Down
![]()
Netprofit is down for the last 4 quarters, 153.5 Cr → -136.19 Cr (in ₹), with an average decrease of 70.6% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 12.32% to 11.71% in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 19.47% to 19.35% in Dec 2025 quarter
View the latest movement in Piramal Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
Piramal Pharma Options
Piramal Pharma Futures
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
Piramal Pharma share price today stands at ₹155.06 as on at the close of the market. Piramal Pharma share today touched a day high of ₹156.09 and a low of ₹149.76.
Piramal Pharma touched a 52 week high of ₹241.35 and a 52 week low of ₹148.31. Piramal Pharma share price today i.e. is closed at ₹155.06, which is -35.75% down from its 52 week high and 4.55% up from its 52 week low.
Piramal Pharma market capitalisation is ₹20,168.68 Cr as on .
To buy Piramal Pharma shares, you need to follow these steps:
Piramal Pharma trading volume is 21.95L as on . This means that 21.95L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.